Home > Resources > Videos > Genetically engineered viruses successfully destroy tumors

Genetically engineered viruses successfully destroy tumors

Viral infections lead to alarmin release and elicit potent cytotoxic effector T lymphocyte (CTLeff) responses. Conversely, the induction of protective tumor-specific CTLeff and their recruitment into a tumor remain challenging tasks. Here we show that lymphocytic choriomeningitis virus (LCMV) can be engineered to serve as a replication competent, stably-attenuated immunotherapy vector (artLCMV).

Spotlight

APIFARMA - Portuguese Pharmaceutical Industry Association

The Portuguese Association of the Pharmaceutical Industry – APIFARMA - was established in 1975, and succeeds the National Guild of the Manufacturers of Medicinal Products, in order to contribute to solving the problems of the sector, for the socioeconomic development of the country, for the improvement of health in Portugal and patient access to new therapies. Currently, APIFARMA represents more than 120 companies responsible for the Production and Marketing of Medicinal Products for Human and Veterinary Use, Vaccines, and In Vitro Diagnostics.

OTHER VIDEOS

The Cardinal Health™ InteLogix™ Platform

video | September 6, 2023

Learn about the industry’s first pharmaceutical supply chain solution that is reducing the cost of care and ensuring access to critical medications for hospitals and health systems....

Watch Now

Aeris: Benchtop XRD for pharmaceutical solid form analysis

video | August 28, 2023

Is solid form characterization critical in your line of work, but you lack expertise in X-ray diffraction (XRD)? Do you need an efficient tool to support you with lead optimization? Do you need an easy way to validate the stability of your solid form following processing?...

Watch Now

Semi-automated testing of on-body delivery systems (OBDS)

video | August 17, 2023

Injection systems that are attached to the patient's body (on-body delivery system OBDS) minimize possible risks, that can occur when drugs are administered by conventional needle-based injection systems (NIS)....

Watch Now

Line Optimizer - digital guided workflows for optimized pharma production operations

video | May 26, 2023

Connectivity in general is becoming an ever more important consideration for production facilities as we endeavour to produce more with less and all the while trying to satisfy an increasing need for more information and communication to and from the production equipment itself....

Watch Now

The Cardinal Health™ InteLogix™ Platform

video | September 6, 2023

Learn about the industry’s first pharmaceutical supply chain solution that is reducing the cost of care and ensuring access to critical medications for hospitals and health systems....

Watch Now

Aeris: Benchtop XRD for pharmaceutical solid form analysis

video | August 28, 2023

Is solid form characterization critical in your line of work, but you lack expertise in X-ray diffraction (XRD)? Do you need an efficient tool to support you with lead optimization? Do you need an easy way to validate the stability of your solid form following processing?...

Watch Now

Semi-automated testing of on-body delivery systems (OBDS)

video | August 17, 2023

Injection systems that are attached to the patient's body (on-body delivery system OBDS) minimize possible risks, that can occur when drugs are administered by conventional needle-based injection systems (NIS)....

Watch Now

Line Optimizer - digital guided workflows for optimized pharma production operations

video | May 26, 2023

Connectivity in general is becoming an ever more important consideration for production facilities as we endeavour to produce more with less and all the while trying to satisfy an increasing need for more information and communication to and from the production equipment itself....

Watch Now
MORE VIDEOS

Spotlight

APIFARMA - Portuguese Pharmaceutical Industry Association

The Portuguese Association of the Pharmaceutical Industry – APIFARMA - was established in 1975, and succeeds the National Guild of the Manufacturers of Medicinal Products, in order to contribute to solving the problems of the sector, for the socioeconomic development of the country, for the improvement of health in Portugal and patient access to new therapies. Currently, APIFARMA represents more than 120 companies responsible for the Production and Marketing of Medicinal Products for Human and Veterinary Use, Vaccines, and In Vitro Diagnostics.

Events